127 related articles for article (PubMed ID: 20142255)
21. Role of antibodies to human papillomavirus 16 in prostate cancer: A seroscreening by peptide microarray.
Zhao X; Zhou Z; Chen Y; Chen W; Ma H; Pu J
Tumour Biol; 2017 Jun; 39(6):1010428317698371. PubMed ID: 28618964
[TBL] [Abstract][Full Text] [Related]
22. Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica.
Coseo S; Porras C; Hildesheim A; Rodriguez AC; Schiffman M; Herrero R; Wacholder S; Gonzalez P; Wang SS; Sherman ME; Jimenez S; Solomon D; Bougelet C; van Doorn LJ; Quint W; Safaeian M;
Sex Transm Dis; 2010 Nov; 37(11):706-14. PubMed ID: 20661178
[TBL] [Abstract][Full Text] [Related]
23. Epidemiologic factors associated with seropositivity to human papillomavirus type 16 and 18 virus-like particles and risk of subsequent infection in men.
Lu B; Hagensee ME; Lee JH; Wu Y; Stockwell HG; Nielson CM; Abrahamsen M; Papenfuss M; Harris RB; Giuliano AR
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):511-6. PubMed ID: 20086109
[TBL] [Abstract][Full Text] [Related]
24. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
Hidalgo-Tenorio C; Ramírez-Taboada J; Gil-Anguita C; Esquivias J; Omar-Mohamed-Balgahata M; SamPedro A; Lopez-Ruz M; Pasquau J
AIDS Res Ther; 2017 Jul; 14(1):34. PubMed ID: 28720147
[TBL] [Abstract][Full Text] [Related]
25. Involvement of human papillomavirus infections in prostate cancer progression.
Al Moustafa AE
Med Hypotheses; 2008 Aug; 71(2):209-11. PubMed ID: 18468811
[TBL] [Abstract][Full Text] [Related]
26. [Distribution of serum antibodies against human papillomavirus 16 and 18 among high-risk women to cervical cancer].
Fei M; Li J; Du J; You J; Zhang S; He W; Kang L; Zhao F; Qiao Y; Si Y; Fan X; Chen W
Zhonghua Liu Xing Bing Xue Za Zhi; 2014 May; 35(5):514-8. PubMed ID: 25059358
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
Anantharaman D; Gheit T; Waterboer T; Abedi-Ardekani B; Carreira C; McKay-Chopin S; Gaborieau V; Marron M; Lagiou P; Ahrens W; Holcátová I; Merletti F; Kjaerheim K; Talamini R; Simonato L; Castellsague X; Macfarlane TV; Biggs AM; Thakker N; Znaor A; Thomson P; Canova C; Conway DI; Healy CM; Tommasino M; Pawlita M; Brennan P
J Natl Cancer Inst; 2013 Apr; 105(8):536-45. PubMed ID: 23503618
[TBL] [Abstract][Full Text] [Related]
28. A multifaceted study of human papillomavirus and prostate carcinoma.
Strickler HD; Burk R; Shah K; Viscidi R; Jackson A; Pizza G; Bertoni F; Schiller JT; Manns A; Metcalf R; Qu W; Goedert JJ
Cancer; 1998 Mar; 82(6):1118-25. PubMed ID: 9506358
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial.
Gray P; Kann H; Pimenoff VN; Eriksson T; Luostarinen T; Vänskä S; Surcel HM; Faust H; Dillner J; Lehtinen M
PLoS Med; 2021 Jun; 18(6):e1003588. PubMed ID: 34097688
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of human papillomavirus antibodies in males and females in England.
Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
[TBL] [Abstract][Full Text] [Related]
31. Risk of HPV-16/18 Infections and Associated Cervical Abnormalities in Women Seropositive for Naturally Acquired Antibodies: Pooled Analysis Based on Control Arms of Two Large Clinical Trials.
Safaeian M; Castellsagué X; Hildesheim A; Wacholder S; Schiffman MH; Bozonnat MC; Baril L; Rosillon D;
J Infect Dis; 2018 Jun; 218(1):84-94. PubMed ID: 29718393
[TBL] [Abstract][Full Text] [Related]
32. Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer.
Dillner J; Knekt P; Boman J; Lehtinen M; Af Geijersstam V; Sapp M; Schiller J; Maatela J; Aromaa A
Int J Cancer; 1998 Feb; 75(4):564-7. PubMed ID: 9466657
[TBL] [Abstract][Full Text] [Related]
33. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
[TBL] [Abstract][Full Text] [Related]
34. Screening of human papillomavirus infection in women with systemic sclerosis.
Martin M; Mougin C; Prétet JL; Gil H; Meaux-Ruault N; Puzenat E; Ramanah R; Aubin F; Touzé A; Coursaget P; Jacquin E; Magy-Bertrand N
Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-145-8. PubMed ID: 25151849
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of human papillomavirus 16 and 18 (HPV-16/18) AS04-adjuvanted vaccine against cervical infection and precancer in young women: final event-driven analysis of the randomized, double-blind PATRICIA trial.
Apter D; Wheeler CM; Paavonen J; Castellsagué X; Garland SM; Skinner SR; Naud P; Salmerón J; Chow SN; Kitchener HC; Teixeira JC; Jaisamrarn U; Limson G; Szarewski A; Romanowski B; Aoki FY; Schwarz TF; Poppe WA; Bosch FX; Mindel A; de Sutter P; Hardt K; Zahaf T; Descamps D; Struyf F; Lehtinen M; Dubin G;
Clin Vaccine Immunol; 2015 Apr; 22(4):361-73. PubMed ID: 25651922
[TBL] [Abstract][Full Text] [Related]
36. Lack of evidence of HPV etiology of prostate cancer following radical surgery and higher frequency of the Arg/Pro genotype in Turkish men with prostate cancer.
Aydin M; Bozkurt A; Cikman A; Gulhan B; Karabakan M; Gokce A; Alper M; Kara M
Int Braz J Urol; 2017; 43(1):36-46. PubMed ID: 28124524
[TBL] [Abstract][Full Text] [Related]
37. HIV is an important risk factor for human papillomavirus types 16 and 18 seropositivity among sexually active men who have sex with men.
Alberts CJ; van Rooijen MS; Prins M; Pawlita M; Schim van der Loeff MF; Waterboer T
Sex Transm Dis; 2015 Mar; 42(3):129-34. PubMed ID: 25668644
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type 16 and risk of preinvasive and invasive vulvar cancer: results from a seroepidemiological case-control study.
Hildesheim A; Han CL; Brinton LA; Kurman RJ; Schiller JT
Obstet Gynecol; 1997 Nov; 90(5):748-54. PubMed ID: 9351758
[TBL] [Abstract][Full Text] [Related]
39. Serological evidence for protection by human papillomavirus (HPV) type 6 infection against HPV type 16 cervical carcinogenesis.
Silins I; Wang Z; Åvall-Lundqvist E; Frankendal B; Vikmanis U; Sapp M; Schiller JT; Dillner J
J Gen Virol; 1999 Nov; 80 ( Pt 11)():2931-2936. PubMed ID: 10580926
[TBL] [Abstract][Full Text] [Related]
40. Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer.
Dillner J; Lehtinen M; Björge T; Luostarinen T; Youngman L; Jellum E; Koskela P; Gislefoss RE; Hallmans G; Paavonen J; Sapp M; Schiller JT; Hakulinen T; Thoresen S; Hakama M
J Natl Cancer Inst; 1997 Sep; 89(17):1293-9. PubMed ID: 9293920
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
